Please note that all times mentioned are CET (Central European Time)

Submitted program are always an exciting part of the Congress. The most notable and exciting work from all abstracts submitted to the congress will be honored with an oral presentation in workshops. Workshop sessions will include pre-recorded presentations with a live connection for discussion. Oral presenters will send in pre-recorded video presentations of their work and will be asked to participate in a question and answer session in real time where presenters are expected to answer questions from the audience about their work.

Cellular Immunology Workshops
Workshop – WS.T1.01
B Lymhocyte Regulation & Function
Date & Time: September 2, 2021 / 11:30 – 12:45
Chairs: TBA
Ondrej Suchanek, United Kingdom – Tissue-resident B cells orchestrate macrophage phenotype and function in non-lymphoid organs
Dessi Malinova, United Kingdom – Novel players in B cell antigen uptake and trafficking
Marta Ferreira Gomes, Germany – Most isotype-switched memory B cells reside in bone marrow or spleen
Nieke van der Bolt, Netherlands – Evolution of the SARS-CoV-2 specific B cell and antibody repertoires over time
Lina Petersone, United Kingdom – IL-21 is a key regulator of chronic germinal centre responses in CTLA-4-deficient mice
Casper Marsman, Netherlands – Termination of CD40L signaling drives human naïve B cell differentiation into antibody-secreting cell formation
Manuel D. Diaz Muñoz, France – The RNA-binding protein HuR is essential for maintenance of the germinal centre response
Workshop – WS.T1.02
T Cell Development
Date & Time: September 3, 2021 / 09:30 – 10:45
Chairs: TBA
Juliette Roels, Belgium – An integrated multi-omics view on human T cell development
Florencia Morganac, Netherlands – Single-cell transcriptomics reveals discrete steps in regulatory T cell development in the human thymus
Jiří Březina, Czech Republic – The rules of engagement of dendritic cells in thymic cooperative antigen transfer
Yanran Zhao, Australia – Functional characterisation and transcriptomic analysis of antigen-specific CD8 T memory stem cells (TSCM) generated from clonally expanded single TSCM cells {in vitro}
Fanny Lafouresse, France – Unique cellular sources of CXCR3 ligands direct intranodal T cell positioning and effector/stem-like memory fates following viral infection
Nesrine Marzougui Ep Essalah, Germany – Relevance of Th17-specific epigenetic signature genes for Th17 differentiation and function
Saumya Kumar, Portugal – Developmental bifurcation of human T follicular regulatory cells
Workshop – WS.T1.03
Innate Immunity
Date & Time: September 1, 2021 / 11:15 – 12:30
Chairs: TBA
Ana Lopes, Netherlands – Deciphering the role of cDC2 in Sjögren’s Syndrome: transcriptomic profile reveals an enhanced antigen uptake and altered antigen processing associated with IFN-signature
Anne Dudeck, Germany – Directional mast cell degranulation of tumor necrosis factor into blood vessels primes neutrophil extravasation
Manuel Stecher, Germany – Mitochondrial Fusion is Critical for Mast Cell Development
Mihai Valache, Italy – Inositol 1,4,5-trisphosphate 3-kinase B promotes Ca2+ mobilization and the inflammatory activity of dendritic cells
Arzuhan Koç, Turkey – Investigating the Molecular and Functional Interaction between Human Macrophages and HiPSC-derived Cardiomyocytes by an {in vitro} Arrhythmia Model
Giacomo Sidoti Migliore, Italy – Bacterial lysate enhances protective mucosal immunity via increased expression of antimicrobial peptides
Guido Wabnitz, Germany – Inflammation induces CCR5-positive pro-NETotic neutrophils via TNFR2 signaling
Workshop – WS.T1.04
Innate Lymphoid Cell
Date & Time: September 3, 2021 / 14:30 – 15:45
Chairs:  TBA
Karlo Mladenić, Croatia – NKG2D ligand recognition by γδ T cells drives steatohepatitis and fibrosis in MAFLD
Luke B Roberts, United Kingdom – MicroRNA-142 is a critical regulator of group 2 innate lymphoid cell homeostasis and function
Jeremy Goc, United States – Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer
Noe Rodriguez Rodriguez, United Kingdom – Identification and characterisation of novel NK cell-restricted aceNK progenitors
Maxime Boy, France – {TET2/IDH} mutations in Myelodysplastic Syndrome patients disrupts Natural Killer cell’s biology
Louise Rethacker, France – Characterization of Human Innate Lymphoid Cell Subsets in Healthy Lymph Nodes
Sophie Flommersfeld, Germany – Adaptive-like NK cell responses are composed of circulating and resident lineages
Workshop – WS.T1.05
Lymphocyte Differentiation
Date & Time: September 4, 2021 / 10:30 – 11:45
Chairs: TBA
Dirk Baumjohann, Germany – Temporal dissection of the T cell-intrinsic factors that maintain T follicular helper cell identity and germinal centers
Dakota Rogers, Canada – Pre-existing chromatin accessibility and gene expression differences among naïve CD4+ T cells influence effector potential
Jun Dong, Germany – Mobilization of tissue-resident memory CD4+ T lymphocytes and their contribution to a systemic secondary immune reaction
Mark Mensink, Netherlands – Proteomic features reflecting unique properties of human thymus-derived and ex vivo regulatory T cells are not present in TGF-beta-induced regulatory T cells
Gabriela Virdzekova, United Kingdom – Akt modulates differentiation of CD8+ memory T cell precursor populations but is dispensable for translational regulation
Gloria Tucci, Italy – T regulatory cells oscillate between a TNF-producing and a TNFR2-expressing status
Yin Xiao, Germany – Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity
Workshop – WS.T1.06
Immune Response Regulation: Cellular Mechanism
Date & Time: September 1, 2021 / 16:00 – 17:15
Chairs: TBA
Maryam Amini, Germany – Role of purinergic signaling in regulating IL-1alpha mediated inflammation in chronic kidney disease
Marca Wauben, Netherlands – Cell-derived vesicles present in human milk dampen innate and adaptive immune responses and enhance epithelial barrier function
Johanna Kotrba, Germany – Mast cell secretory granules are endogenous c-type lectin receptor ligands skewing dendritic cell function towards Th2/Th17 response
Alaz Özcan, Switzerland – CCR7-guided neutrophil redirection to skin-draining lymph nodes regulates cutaneous inflammation and infection
Konstantinos Katsoulis Dimitriou, Germany – Peripheral mast cell-derived RANKL is a prerequisite for lymphocyte egress from distant lymph nodes
Tyrza Van Leeuwen, Netherlands – Enrichment of bioorthogonal antigens from dendritic cells to study antigen processing on peptide level
Cynthia M. Fehres, Netherlands – Autoantibodies isolated from Systemic Sclerosis patients targeting the angiotensin II type 1 and endothelin-1 type A receptor induce endothelial cell activation and pro-fibrotic cellular responses
Workshop – WS.T1.07
T Lymphocyte Function
Date & Time: September 2, 2021 / 17:15 – 18:30
Chairs: TBA
Jun Abe, Switzerland – CD8+ T cells require signal 3 from non-antigen-presenting cells for optimal clonal expansion
Marta Fortunatoi, Italy – IL-10 engineered Dendritic Cells modulate allogeneic cytotoxic CD8+ T cells response {in vitro}
Bin Qu, Germany – Targeting the microtubule-network to improve CTL killing capacity in dense 3D matrices
Michael Berger, Israel – Systemic hypoxia inhibits T cell response by limiting mitobiogenesis via matrix substrate-level phosphorylation arrest
Alexandra H Mandarano, United States – Copper homeostasis is required for T cell activation
Lucy C. Garner, United Kingdom – Extrinsic factors govern human MAIT cell transcriptional and functional plasticity
Duncan R Mckenzie, United Kingdom – Normality-Sensing Licenses Local T cells for Innate-like Tissue-surveillance
Workshop – WS.T1.08
Immune Response in Disease
Date & Time: September 3, 2021 / 09:30 – 10:45
Chairs:   TBA
Sergio Gil Manso, Spain – ABO-group and age are individuals factors associated with specific T-cell memory in long-term immunity after COVID-19
Bérengère Salomé, United States – NKG2A and HLA-E define an additional immune checkpoint axis in bladder cancer
Anastasia Prokopi, Netherlands – High dimensional analysis of the human lymph node during melanoma progression reveals shifts in myeloid content that relate to differential T cell content
Rémi Marrocco, France – Themis1/vav1 signaling hub controls t cell pathogenicity in a mouse model of multiple sclerosis
Acelya Yilmazer Kirgin, Germany – Distinct Roles of Foxp3+ Regulatory T Cell Sublineages in Adipose Tissue Homeostasis and Obesity
Stefan Meltendorf, Germany – Insufficient up-regulation of YB-1 leads to failed CD4+ T cell survival of patients with SLE
Mustafa Kaya, Turkey – Role of Treg/Th17 Imbalance at the Immunity or Tolerance in Myasthenia Gravis
Workshop – WS.T1.09
Myeloid Lineage
Date & Time: September 1, 2021 / 16:00 – 17:15
Chairs:   TBA
Tim Willinger, Sweden – Distinct developmental pathways from blood monocytes generate human lung macrophage diversity
Calum C Bain, United Kingdom – Dissecting the transcriptional control of airway macrophages: a key role for EGR2
Xin Lei, Netherlands – Flagellin/TLR5 stimulate myeloid progenitors to enter lung tissue and to locally differentiate into macrophages
Sophiya Tabassum Tahir Siddiqui, Germany – Targeting lipid droplet metabolism in tumor associated macrophages as a novel approach to target tumor progression
Jake Thomas, United Kingdom – Identification and characterisation of Hofbauer cell progenitors in the first trimester human placenta
Jesper Van Eck Van Der Sluijs, Netherlands – High-dimensional flow-cytometry and functional evaluation reveals enhanced potency of stem cell-derived dendritic cell bulk vaccination to boost T cell immunity
Laura Marongiu, Italy – Molecular signature of conventional dendritic cell subtypes in COVID-19 disease
Workshop – WS.T1.10
T Lymphocyte Regulation and Function
Date & Time: September 3, 2021 / 17:15 – 18:30
Chairs: TBA
Mariana Borsa, United Kingdom – Retaining memory: Virtual memory CD8+ T cells as an adaptive mechanism of the ageing immune system
Svenja Rapelius, Germany – T cell stemness during chronic infection is maintained by only a subcompartment of TCF1+ cells
Katharina Hochheiser, Australia – ¬¬Protein tyrosine phosphatase non-receptor type 2 and killer cell lectin-like receptor G1 regulate the generation and function of tissue-resident memory T cells in skin
Cansu Yerinde, Germany – HDAC7 controls CD8+ T cell dependent anti-viral and anti-tumor immunity
Ling Li, Netherlands – Bryostatin exerts anti-tumor effects by reversing T cell exhaustion
Maria Davern, Ireland – Cooperation between chemotherapy and immunotherapy to enhance anti-tumour T-cell mediated immunity in oesophageal adenocarcinoma; implications for synergistic combination regimens
Christina Zielinski, Germany – Single-cell chimerism analysis and transcriptional profiling identify long-term human tissue-resident host T cells in the skin after allogeneic stem cell transplantation
Molecular and Cellular Mechanisms
Date & Time: September 4, 2021 / 12:00 – 13:15
Chairs: TBA
Maria Metsger, Czech Republic – Identification of a CD106+ pericyte stem cell leading to Ly6G+ cell accumulation responsible for resistance to immunotherapy in pancreatic cancer
Zhichong Wu, France – Identification of a CD106+ pericyte stem cell leading to Ly6G+ cell accumulation responsible for resistance to immunotherapy in pancreatic cancer
Diletta Di Mitri, Italy – Heterotypic signaling between tumor cells and lipid-loaded macrophages drives tumor progression and resistance to therapy in cancer
Yingying Wei, China – JAK2/STAT5 signaling controls T cell polarization and development of experimental autoimmune encephalomyelitis
Thomas Riffelmacher, United States – Metabolic Fuel Choices Control MAIT Cell Functions at Homeostasis and after Infection
Thomas Liechti, United States -Leveraging high-dimensional flow cytometry to assess human immune homeostasis at population-wide scale
Simge Senay, Turkey – The effect of High-Density Lipoprotein (HDL) on autophagy and mitochondrial dynamics in a monocytic cell line
Molecular Immunology Workshops
Workshop – WS.T2.01
Immune Regulation and Signaling
Date & Time: September 1, 2021 / 16:00 – 17:15
Chairs:  TBA
Felix Bayerl, Germany – PGE2 signaling reprograms the cDC1 transcription factor network to promote cDC1 dysfunctionality in tumors and limit cancer immune control
Ioannis Kienes, Germany – DDX3X Links NLRP11 to the Regulation of Type I Interferon Responses and NLRP3 Inflammasome Activation
Fiona Leslie, United Kingdom – Defining the rapid actions of glucocorticoids in the lung
Anna S Tocheva, United States – Functional T cell diversity drives differences in PD-1 signaling
Kata Petra Szilveszter, Hungary – Characterizing the Role of PLCγ2 in Autoantibody-induced Skin Blistering
Iva Hafner Bratkovic, Slovenia – Molecular mechanisms of NLRP3 inflammasome activation and its regulation
Pablo Pelegrín, Spain – Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation
Workshop – WS.T2.02
Immune Regulaltion and Transcriptional modulation
Date & Time: September 1, 2021 / 11:15 – 12:30
Chairs: TBA
Sofia Piepoli, Turkey – Sibling rivalry among the ZBTB transcription factor family: homo vs heterodimerization
Lili Gu, Ireland – MNDA controls the pathogen-stimulated type I interferon cascade in human monocytes by transcriptional regulation of IRF7
Sudheendra Hebbar Subramanyam, Germany – Foxp3-specific deletion of CREB generates Th2 biased ST-2 positive regulatory T-cells with enhanced IL-10 production and suppressive capacity
Panagiota Davoulou, Greece – The molecular interplay of Ets-2-Tip60 and its role in the pathogenesis of multiple sclerosis (MS)
Nivas Shyamala, India – HMGCR gene polymorphisms (rs33761740, rs3846662) and promoter DNA methylation association with serum lipids in coronary artery disease
Stefan Floess, Germany – Organ-specific inflammation-driven changes in the epigenetic signature of murine ILC2s
Shafaqat Ali, Germany -The transcription factor BATF limits the expression of type I interferon in plasmacytoid dendritic cells
Workshop – WS.T2.03
Immune Response Regulation: Metabolism
Date & Time: September 2, 2021 / 11:30 – 12:45
Chairs: TBA
Carlos Plaza Sirvent, Germany – The autophagy core protein ATG5 is essential to maintain intestinal RORgt+ Foxp3+ Treg cells
Lea Katharina Boller, Germany – Effect of glucose-transporter inhibitors on the function of Natural Killer cells
Belen Garcia Fojeda, Spain – Alveolar lipids regulate the response of alveolar macrophages to IL-4
Remsha Afzal, Ireland – Mitochondrial arginase-2 is essential for IL-10 mediated metabolic reprogramming of inflammatory macrophages
Shannon L Cox, Ireland – Circadian disruption increases the inflammatory response of lung fibroblasts
Sue Mckay, Netherlands – Pectic polysaccharide RG-I from bell pepper and carrot stimulates protective innate immune responses and modulates gut microbiota in humans
Gabriela Sarango, France – The autophagy receptor TAX1BP1 (T6BP) is a novel player in viral antigen presentation by MHC-II molecules
Workshop – WS.T2.04
Immune Response Regulation in Diseases
Date & Time: September 4, 2021 / 12:00 – 13:15
Chairs: TBA
Eveline Le Nours, Sweden – Anti-MDA5 autoantibodies in myositis patients specifically target the Helicase domains of the MDA5 protein
Tamara Verkerk, Netherlands – Expression of neolacto-series glycosphingolipids by tumors impairs the function of low-affinity immune receptor-ligand pairs
Karina Pino Lagos, Chile – Small extracellular vesicles obtained from Nrp1+ T regulatory cells favor skin graft tolerance
Evelyn Kelemen, Hungary – PRINS long non-coding RNA regulates IL-23 expression of keratinocytes
Christina Molina Lopez, Spain – Activation mechanism and secretome characterization of NLRP3 mutants associated to cryopyrin periodic syndromes
Karen Yu, Belgium – Discovery of citrullination of MMP-9 in rheumatoid arthritis synovial fluid
Sara Abouelasrar, Belgium – The inflammatory nature of serum amyloid A (SAA): fact or fallacy?
Workshop – WS.T2.05
Immune Regulation by Immune Receptors
Date & Time: September 4, 2021 / 12:00 – 13:15
Chairs:  TBA
Julian P Vivian, Australia – Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
Jerome Le Nours, Australia – The structure of the marsupial γμ T cell receptor defines a third T cell lineage in vertebrates
Xiaoli Yang, Germany – The natural ompound Beauvericin exhibits immunostimulatory effect on dendritic cells via activating TLR4 signaling pathways
Helen Von Richthofent, Netherlands – Signal Inhibitory Receptor on Leukocytes-1 is an inhibitory Pattern Recognition Receptor that recognizes bacterial and endogenous amphipathic α-helical peptides
Marie Astrid Boutet, France – Pentraxin-3 (PTX3) Circulating And Synovial Expression Levels Correlate With Rheumatoid Arthritis Severity And Tissue Infiltration Independently Of The Response To Conventional Treatments
Rebeca F Megino, Spain – Cells deficient in membrane complement regulators as biosensors of abnormal complement deposition
Dayana Hristova, United Kingdom – DNA-PK is required for viral DNA sensing in human cells
Workshop – WS.T2.06
Immune Regulation and Big Data
Date & Time: September 4, 2021 / 10:30 – 11:45
Chairs: TBA
Gregory Ehx, Belgium – BamQuery: A new proteogenomic tool to explore the immunopeptidome and validate tumor-specific antigens
Necla Kochan, Turkey – Discovery of subtype specific markers through Fuzzy Logic and Non-parametric approaches using Transcriptomic data in immune related Colon cancer
Virginia Smit, Netherlands – Single-cell profiling of age-associated immunity in murine atherosclerosis
Ozlem Bulut, Netherlands – Identification of Common Metabolic Markers of Immune Aging In Western European and African Populations
Lorenzo Bonaguro, Germany – Natural human variation in multi-layered cohorts predicts the function of CRELD1: a novel regulator of immune homeostasis in mouse and human
Christos Nikolaou, Germany – Mass cytometry analysis of the murine hematopoietic system reveals signatures induced by ageing and physiological pathogen challenges
Timurs Maculins, United States – Multiplexed proteomics of autophagy deficient macrophages reveals enhanced antimicrobial immunity via the oxidative stress response
Diseases and Immune Responses Workshops
Workshop – WS.T3.01
Allergy and asthma
Date & Time: September 1, 2021 / 11:15 – 12:30
Chairs: TBA
Iris Bellinghausen, Germany – Oral administration of short chain fatty acids to PBMC-engrafted humanized mice prevents allergen-dependent airway and intestinal inflammation
Mathias Hochgerner, Austria – Hypoxia ameliorates allergic asthma {in vivo} by interfering with immune cell cross-talk
Pattraporn Satitsuksanoa, Switzerland – Characterisation of allergen-specific B cell tolerance in children with cow’s milk-oral immunotherapy and natural outgrow of milk allergy
Willem Van De Veen, Switzerland – In depth analysis of the bee venom allergen-specific B cell repertoire in immunotherapy-treated venom allergic individuals and naturally exposed healthy beekeepers
Mareike Ahrends, Germany – Asthma-associated immunological responses in RSV infections on primary human lung tissue {ex vivo}
Charlotte Castenmiller, Netherlands – The major peanut allergens Ara h 1, 2, 3 and 6 are taken up by dendritic cells via different routes and receptors
Xinran Zhao, Sweden – Mast cell chymase affects the functional properties of primary human lung fibroblast: implications for asthma
Workshop – WS.T3.02
Cellular Mechanism of  Inflammatio
Date & Time: September 1, 2021 / 13:00 – 14:15
Chairs:  TBA
Riem Gawish, Austria – Determinants of susceptibility in mice infected with mouse-adapted SARS-CoV-2
Sarajo Mohanta, Germany – Neuroimmune Cardiovascular Interfaces in Atherosclerosis
Silvia Ariño, Spain – Infiltrating neutrophils present an aged phenotype and an altered recruitment dynamics and functionallity in chronic liver disease
Rafael Blanco Dominguez, Spain – CD69 expression on regulatory T cells protects from immune-mediated damage after myocardial infarction
Mehmet Ceylan, Turkey – Colchicine limited secondary lung injury in an experimental rat sepsis model
Milica Vujičić, Sweden – Critical role of resident M2-like macrophages in healthy subcutaneous adipose tissue expansion
Tanja Džopalić, Serbia – The role of interleukin-6 in pathogenesis of apical periodontitis studied by flow cytometry and cell cultures
Workshop – WS.T3.03
Molecular Mechanisms of Inflammation
Date & Time: September 1, 2021 / 11:15 – 12:30
Chairs: TBA
Prasenjit Mitra, India – Assessment of changes in the expression of immunomodulatory miRNAs (miR-20b, miR-155 and miR-221) in workers occupationally exposed to Cadmium
Nikolina Mihaylova, Bulgaria – Anti-inflammatory effect of Crocus sativus extract evaluated in a murine model of osteoarthritis
Yasmina Esther Hernández Santana, Ireland – Regulation of IL-36 receptor driven skin in inflammation in psoriasis
Lauren E. Fagan, Ireland – A Novel Role for Nutrient Receptors in Cartilage and Joint Disease
Radha Asher, United Kingdom – Glycolysis is a key driver of tissue degradation and remodelling in tuberculosis
Xinxin Luo, Sweden– Liver X receptor activation promotes intestinal repair while limiting tumorigenesis
Daniel Leonard Seiler, Germany – C5aR2 deficiency ameliorates inflammation in antibody transfer-experimental {epidermolysis bullosa acquisita} and reveals promoting of C5aR1 signaling outcomes
Workshop – WS.T3.04
Exploiting host pathogen interaction
Date & Time: September 4, 2021 / 10:30 – 11:45
Chairs:  TBA
Raffaella Parente, Italy – The long pentraxin PTX3 at the host-pathogen interface in {Staphylococcus aureus}-dependent osteomyelitis
Matthieu Paiola, United States – Role of MHC class I-like XNC4 during mycobacterial infection in two developmental stages in {Xenopus}
Alanna M Kelly, Ireland – {Staphylococcus aureus}-induced immunosuppression facilitates persistence during nasal colonisation
Tobias K Dallenga, Germany – Prevention of Mycobacterium tuberculosis-induced neutrophil necrosis restricts bacterial proliferation and may represent a target for a host-directed therapy
Gul Kilinc, Netherlands – Development and employment of a human cell-based {in vitro} {Mycobacterium avium} infection model to identify host-directed therapeutics as a novel treatment strategy
Julia Kutschenreuter, United Kingdom – Neutrophil-dependent secretion of the biomarker LRG1 in Tuberculosis
Sebastian Baasch, Germany – Cytomegalovirus subverts macrophage identity
Workshop – WS.T3.05
Genetic and environmental triggers of autoimmunity
Date & Time: September 1, 2021 / 13:00 – 14:15
Chairs: TBA
Cristoforo Grasso, Netherlands – Identification and mapping of distinct human lymph node stromal cell subsets by combining single cell RNA sequencing with spatial transcriptomics
Alice Lepelley, France – cGAS-STING-dependent interferon signalling in a mitochondrial disease
Jamie van Langelaar, Netherlands – Preferential induction of brain-homing T-bet+ B cells by infectious triggers in multiple sclerosis patients
Bert Malengier Devlies, Belgium – Lung Functioning and Inflammation in a Mouse Model of Systemic Juvenile Idiopathic Arthritis
Etienne Masle Farquhar, Australia – EGR2 and EGR3 prevent uncontrolled accumulation of B1 and CD21low age-associated B cells
Maartje G Huijbers, Netherlands – Functional monovalency of IgG4 autoantibodies amplifies their pathogenicity in MuSK myasthenia gravis
María Botía Sánchez, Spain – Characterising the relation between genetic background and gut immune response against microbiota in a murine model of lupus
Workshop – WS.T3.06
Immune deficiencies
Date & Time: September 1, 2021 / 16:00 – 17:15
Chairs: TBA
Sevil Oskay Halaçlı, Turkey – The imbalance of the circulating regulatory B cell subsets in patients with primary immunodeficiencies
Manfred Anim, Germany – Novel heterozygous missense mutations in NFkB1 causes immunedysregulation and immunodeficiency
Marion Ciudad, France – Warm autoimmune hemolytic anemia is associated with a regulatory T cell deficiency and a Th17 polarization
Liat Stoler Barak, Israel – The role of DYRK1A in B cell immune responses
Meryem Demir, Turkey – COVID-19 in patients with primary and secondary immunodeficiencies: A single-center experience
Jiahui Luo, China – Targeted inhibition of FTO demethylase protects mice against LPS-induced septic shock by suppressing NLRP3 inflammasome
Merve Selcuk, Turkey – CHAPLE Disease and Non-CHAPLE Protein Losing Enteropathies: Natural History and Immune Characteristics
Workshop – WS.T3.07
Immune regulation in cancer
Date & Time: September 3, 2021 / 09:30 – 10:45
Chairs: TBA
Paulo Rodrigues Santos, Portugal -Immune profiling of soft tissue sarcoma: cellular, proteomic and transcriptomic analysis of peripheral blood
Alexander Simpson, United Kingdom – FcγRIIB-mediated inhibition of antibody-mediated target cell depletion is independent of ITIM signalling
 Marina Patysheva, Russia – СD14low16highHLA-DR+ monocytes are increased in breast cancer patients with good response to neoadjuvant chemotherapy
Suzanne M Castenmiller, Netherlands – Cytokine-producing tumor-infiltrating lymphocyte products can be effectively generated from pre-treated late stage non-small-cell lung cancer (NSCLC) lesions irrespective of location and pre-treatment regimens
Monika Homolya, Austria – Downregulation of A20 promotes immune escape of lung adenocarcinomas
Yvonne Vercoulen, Netherlands – Single cell spatial analysis reveals changes in the tissue immune landscape during initiation of colitis associated cancer in patients
Domenico Supino, Italy – IL-1R8 acts as an immune checkpoint in CD8+ T cells
Workshop – WS.T3.08
Maintenance and local regulation of tissue specific immunity
Date & Time: September 2, 2021 / 11:30 – 12:45
Chairs: TBA
Michael Dudek, Germany – Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
Lilja Hardardottir, Germany – The critical expansion of uterine CD8+ T cells in pregnancy is under tight homeostatic control
Alexandra Argyriou, Sweden – Single cell sequencing reveals expanded cytotoxic CD4+ T cells and two states of peripheral helper T cells in synovial fluid of ACPA+ Rheumatoid Arthritis patients
Christian Schwartz, Germany – Innate PD-L1 limits T cell mediated adipose tissue inflammation
Hendrika W Grievink, Netherlands – Stimulation of the PD-1 pathway decreases atherosclerotic lesion development in Ldlr deficient mice
Masa Filipovic, Croatia – Increased inflammatory parameters, chemokines and chemokine receptors in obese children
Gráinne Jameson, Ireland – Human intrahepatic CD56bright NK cells display a tissue-resident transcriptional profile and enhanced ability to kill allogenic CD8+ T cells
Workshop – WS.T3.09
Microbial, fungal, and parasitic immunology
Date & Time: September 2, 2021 / 17:15 – 18:30
Chairs: TBA
Giulia Stucchi, Italy – Role of danger and microbial signals in the control of the recruitment of neutrophil subpopulations during infections
Matthias H Enders, Australia – Liver resident CD4 T cells in malaria infection
Mimmi L E Lundahl, Ireland – Macrophage Innate Training Induced by IL-4 Activation Enhances OXPHOS Driven Anti-Mycobacterial Responses
Thierry Roger, Switzerland – Trained immunity confers prolonged protection against systemic listeriosis
Marco De Zuani, Czech Republic – Sepsis induces long-term reprogramming of human hematopoietic stem cells
Mads Delbo Larsen, Netherlands – Afucosylated IgG is naturally produced in response to intracellular pathogens including SARS-CoV-2 and {Plasmodium falciparum} but not by subunit vaccination
Antonio Inforzato, Italy – The alternative pathway of complement and long pentraxin PTX3 form a functional axis in the immune response to Aspergillus fumigatus
Workshop – WS.T3.10
T Cells in Atopy, Transplantation and Tolerance
Date & Time: September 4, 2021 / 12:00 – 13:15
Chairs: TBA
Joyce Lübbers, Netherlands – Tolerance induction with vitamin D3, Dexamethasone or sialic acids influences maturation status and metabolic activity in human dendritic cells
Thiruni N Adikari, Australia – Single cell RNA sequencing of gluten-specific CD4+ T cells reveals a novel gene expression pattern with NK-like cytotoxicity
Olatz Zenarruzabeitia, Spain – PD-1 expressing regulatory T cells and basophils with an activating profile in infants with moderate-to-severe Atopic Dermatitis hypersensitized to food antigens
Marygrace Duggar, United States – The role of DRAK2 in Graft versus Host Disease
Anton Althammer, Germany – CD28 Superagonist TAB08-mediated activation and expansion of human regulatory T cells might protect patients from acute Graft versus Host Disease
Maria Luisa Del Rio Gonzalez, Spain – CD160, a CD28 alternative costimulatory molecule of alloreactive CD8 T cells unable to prevent NK cell-mediated mechanisms of rejection
Johanna Strobl, Austria – Re-circulating tissue-resident memory T cells are poised for a systemic Th2-driven host-versus-graft reaction after human allogeneic hematopoietic stem cell transplantation
Workshop – WS.T3.11
Microbiota and Mucosa
Date & Time: September 4, 2021 / 12:00 – 13:15
Chairs: TBA
Israel Olivas Martinez, Spain – Dysbiosis in gut mucosa in relation to CD4 counts at cART onset and CD4 recovery
Lisa Budzinski, Germany – Using multiparameter flow cytometry to understand microbiota-host crosstalk in chronic inflammatory diseases
Ana Santos Almeida, Ireland – Fibre-associated Lachnospiraceae reduce colon tumorigenesis by modulation of the tumour-immune microenvironment
Marketa Vavreckova, Czech Republic – High-protein diet and TLR9 knock out effect on the immune responses in the development of colorectal cancer
Jenny Mary Mannion, Ireland – Potential pathogenic role for respiratory symbionts in the development of self-reactive Th17 cells
Diana Elena Matei, United Kingdom – Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease
Marc Lindenberg, Germany – Clarithromycin impairs tissue-resident memory and Th17 responses to macrolide-resistant {Streptococcus pneumoniae} infections
Workshop – WS.T3.12
Mucosal Immunity
Date & Time: September 3, 2021 / 17:15 – 18:30
Chairs: TBA
Federica Laudisi, Italy -GATA6 deficiency leads to epithelial barrier dysfunction and enhances susceptibility to gut inflammation
Marilena Letizia, Germany – Store-operated calcium entry controls immune cell function and activation in inflammatory bowel disease
Daniëlle M.H. Barendregt, Netherlands – Expression of the coinhibitory receptor TIGIT on memory CD4+ T cells is induced by TCR ligation and retinoic acid co-stimulation and is elicited during microbial colonization of the intestine
Mangge Zou, Germany – Early-life vitamin A treatment rescues neonatal infection-induced long-lastingly impaired lymph node operativeness
Jochen Mattner, Germany – Arginase 1 inhibits the resolution of colitis due to the consumption of L-arginine and the expansion of an inflammatory microbiota
Laura F. Ouboter, Netherlands – Identification of a disease-associated network of intestinal immune cells in treatment-naïve inflammatory bowel disease
Jonathan Wai Pang Lo, United Kingdom – Immune checkpoint inhibitor-induced colitis is mediated by IL23 responsive CD90+ cytotoxic lymphocytes
Workshop – WS.T3.13
Neuroinflammation
Date & Time: September 2, 2021 / 17:15 – 18:30
Chairs:  TBA
Emeline Joulia, France – Eomes controls central nervous system inflammation by increasing survival of effector CD4 T cells through the regulation of mitochondrial metabolism
Steven Koetzier, Netherlands – Towards the suppression of the disease-relevant brain-homing CD4+ T cell in multiple sclerosis
Zhana Haimon, Israel – Defining the role of microglia in Relapsing-Remitting EAE
Doryssa Hermans, Belgium – Oncostatin M opens the gate for T helper 17 cells during neuroinflammation
Henning Ulrich, Brazil – Kinin-B2 receptor signaling in neuroinflammation and innate immune response in Alzheimer’s disease
Malgorzata Krzyzowska, Sweden – Fas/FasL contributes to HSV-1 brain infection and neuroinflammation
Judith Fraussen, Belgium – Circulating immune profile changes reflect memory immune responses in spinal cord injury patients
Workshop – WS.T3.14
Tumor microenvironment
Date & Time: September 3, 2021 / 17:15 – 18:30
Chairs:  TBA
Silvia Carnevale,Italy – Neutrophils controlling the intestinal microbiota provide protection against colitis and colitis-associated colorectal cancer
Hannah Egan, Ireland – The T-cells Sweet Tooth: T-lymphocytes exposed to highly sialylated cancer associated fibroblasts present an exhausted phenotype, which can be reversed through desialylation
Luigi D’Antonio, Italy – Hindering triple negative breast cancer progression by targeting endogenous Interleukin-30 requires IFNγ signaling
Yasmine Lounici, France – Complementary but distinct protective roles of breast tumor-infiltrating IgG and IgA producing cells
Marie Laviron, France – Tumor-associated macrophages heterogeneity is driven by distinct niches in breast cancer
Costanza Maria Cristiani, Italy – Frequencies and functional properties of Innate Lymphoid Cells are altered in melanoma patients and modulated by immune checkpoints inhibitors
Ioana Plesca, Germany – Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer
Workshop – WS.T3.15
Immunoregulation and Tumor microenvironment
Date & Time: September 4, 2021 / 10:30 – 11:45
Chairs: TBA
Mussarat Wahid, United Kingdom – Targeting PD1/PDL1 pathway by endogenous recombinant soluble PD1
Samuele Notarbartolo, Italy – Single-cell transcriptional and repertoire profiling of CD4+ TILs unveils distinct immune evasion strategies in primary and metastatic CRC
Felix Simon Ruben Picard, Germany – IL-17-producing CD8 T cells associate with poor survival in PDAC and promote carcinogenesis via induction of inflammatory cancer associated fibroblasts
Julian Swatler, Poland – Leukemic extracellular vesicles drive highly suppressive regulatory T cells by modulating mTOR and STAT5 signaling, leading to progression of myeloid leukemia
Pia Gamradt, France – Alk4 disruption in Kras-induced pancreatic cancer remodels mechanical and immunologic properties of the tumor microenvironment
Alexander Visekruna, Germany– Depending on the tumor microenvironment, immunoproteasomes exert pro- or anti-tumorigenic effects
Tatjana Bilich, Germany – Characterization of pre-existing and post-infectious immune responses to SARS-CoV-2 in cancer patients
Workshop – WS.T3.16
Viral Immunology 1
Date & Time: September 3, 2021 / 14:30 – 15:45
Chairs: TBA
Valeria Fumagalli, Italy – Group 1 innate lymphoid cells regulate T cell-mediated liver immunopathology by controlling local interleukin-2 availability
Ezgi Akidil, Germany – Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection
Claudia De Pasquale, Italy – Hepatitis B virus negatively impacts the protective Immune crosstalk between Natural Killer and Dendritic Cells
Simona Saluzzo, Austria – Loss of skin CXCR3+ CD4+ tissue-resident T cells causes irreversible skin-confined immunodeficiency in HIV late presenters
Laura Ospina Quintero, Germany – A two-photon imaging platform for investigating cytotoxic T lymphocyte dynamics in virus-infected explanted lungs
Lavinia Franchitti, United States – CD8+ lymphocyte mediated suppression of HIV expression in CD4+ T cells
Tomer Hertz, Israel – IgA immune history profiles predict influenza disease in vaccinated and unvaccinated individuals
Workshop – WS.T3.17
Viral Immunology 2
Date & Time: September 3, 2021 / 09:30 – 10:45
Chairs: TBA
Hannah Kaminski, France – mTOR inhibitors prevent CMV infection through the restoration of functional gamma-delta and alpha-beta T cells in kidney transplantation
Martina Anzaghe, Germany – Type I interferon receptor-independent interferon-alpha induction upon infection with a variety of negative-strand RNA viruses
Francesco Andreata, Italy – Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming
Eleonora Sala, Italy – Dissecting the role of IFN-𝛾 in antiviral CD4+ T cell fate
Marwa Abd Alhadi, Israel – Obesity is associated with an altered baseline and post-vaccination influenza antibody repertoire
Jonathan M Gibbins, United Kingdom – Aberrant glycosylation of anti-SARS-CoV-2 IgG is a pro-thrombotic stimulus for platelets
Jun Siong Low, Switzerland – A rapid screening strategy identifies a pan-coronavirus neutralizing antibody
Workshop – WS.T3.18
COVID 19 – 1
Date & Time: September 3, 2021 / 14:30 – 15:45
Chairs: TBA
Seppe Cambier, Belgium – Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019
Sara Falck Jones, Sweden – Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
Anna C. Aschenbrenner, Germany – Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
Julia Eder, Netherlands – Infection and transmission of SARS-CoV-2 depends on heparan sulfate proteoglycans
Julia Niessl, Sweden – Identification of SARS-CoV-2-cross-reactive resident memory CD8+ T cells in oropharyngeal lymphoid tissue
Digdem Yoyen Ermis, Turkey – The distribution of mature and/or immature myeloid cells and their role in effective anti-viral immune responses in COVID-19 positive patients
Alberto Utrero Rico, Spain – Changes in circulating monocytes predict severity during acute COVID-19 and include chromatin modifications still detectable six months after recovery
Workshop – WS.T3.19
COVID 19 – 2
Date & Time: September 4, 2021 / 10:30 – 11:45
Chairs: TBA
Cevriye Pamukcu, Turkey – A Colorimetric Pseudovirus-based Assay Using Secreted Embryonic Alkaline Phosphatase for Analysis of Neutralizing Activity Against SARS-CoV-2
Fatma Savran Oguz, Turkey – The influence of HLA genotype on the severity of COVID-19 infection
Büşranur Geçkin, Netherlands – The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune responses
Ljiljana Sofronic Milosavljevic, Serbia – Immunomodulatory Effect of IgM/IgA-enriched High Dose Intravenous Immunoglobulin Therapy in Covid-19 Patients
Jonas Schulte-Schrepping, Germany – Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Chiara E. Geyer, Netherlands – Hyper-inflammation in severely ill COVID-19 is induced by early phase anti-SARS-CoV-2 IgG and can be specifically counteracted by FDA/EMA-approved small molecule inhibitors
Abdurrahman Simsek, Turkey – Peripheral CD39-expressing regulatory T cell subsets play an age-dependent role in the severity of COVID-19
Workshop – WS.T3.20
COVID 19-3
Date & Time: September 4, 2021 / 12:00 – 13:15
Chairs: TBA
Patricia Suàrez Fernández, Spain – Circulatory T Follicular Helper cell (cTFH) profile during SARS-CoV-2 infection
Jyothi N. Purushotham, United States – Multi-omics analysis of the age-related effects of SARS-CoV-2 infection in rhesus macaques
Jet Van Den Dijssel, Netherlands – Parallel detection of SARS-CoV-2 epitopes in convalescent COVID-19 patients reveals immunodominance and memory CD8+ T cells
Caoimhe H. Kiernan, Netherlands – SARS-CoV-2-specific T cell immunity is retained 12 months post-infection and is dependent on CD4 T cells
Kilian Schober, Germany – Single-cell RNA sequencing reveals in vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’
Lisan Kuijper, Netherlands – Deep immune phenotyping of SARS-CoV-2 specific B cell profiles after primary infection
Alessio Mazzoni, Italy – First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in recovered COVID-19 subjects
Workshop – WS.T3.21
Inflammation and genetic effects
Date & Time: September 4, 2021 / 12:00 – 13:15
Chairs: TBA
Sanne Mol, Netherlands – Hyaluronic acid in synovial fluid in inflamed joints inhibits neutrophil activation
Matheus Silvério Mattos, Belgium – Prolonged neutrophil survival at necrotic sites is a fundamental feature for tissue recovery and resolution of hepatic inflammation
Catriona Walls, United Kingdom – The Role of Siglec-9 in ANCA-associated Vasculitis
Safa Baris, Turkey – Reversal clinical and immunological effects of abatacept in patients with LRBA and CTLA4 deficiencies
Tania Gajardo, France – TTC7A/PI4KIIIα pathway controls leukocytes’ migration
Elissa Deenick, Australia – Dissecting the cellular defects that lead to activated PI3K δ Syndrome (APDS)
Lukács Sándor Lesinszki, Hungary – Src-family kinases in immune complex-mediated glomerulonephritis
Diseases and Innovative Technologies
Date & Time: September 4, 2021 / 10:30 – 11:45
Chairs: TBA
Elena Jachetti, Italy –  Systems analysis reveals the unique immune system organization in the long-lived rodent Spalax
Rizwan Ahmed, United States – A novel monoclonal antibody (x-mAb) produced by a newly discovered lymphocyte (DE cells) identifies universal autoreactive T cells that are associated with self-related immunity
Ann Kathrin Reuschl, United Kingdom – Evolution of enhanced innate immune evasion in lung epithelial cells by the SARS-CoV-2 B.1.1.7 variant
Jasmin Scheurer, Germany -3D human skin models of inflammatory skin diseases psoriasis and atopic dermatitis
Piotr Trzonkowski, Poland -From bench to bedside – Clinical therapy with T regulatory cells
Sabriye Senem Kılıç, Turkey -Cellular Response of HaCaT Keratinocytes in Co-Culture With {Staphylococcus Aureus} in Bacterial Cellulose-Based Antibacterial Wound Dressings
Soren Reinke, United Kingdom – Novel adjuvants that promote the efficacy of R21 malaria vaccine candidate in a mouse model
Innovative Technologies and Immunotherapies Workshops
Workshop – WS.T4.01
Bioinformatics and Immunology
Date & Time: September 1, 2021 / 11:15 – 12:30
Chairs: TBA
Alexander Y Komkov, Russia – The hidden stage of V(D)J-recombination: examination of the first time discovered human TRB D1-D2 rearrangements repertoires
Charlotte L. Scott, Belgium – Using Spatial Proteogenomics to create a practical cell atlas of the murine and human liver
Daniel Toro Domínguez, Spain – Personalized molecular portraits of Systemic Lupus Erythematosus patients as key for prognosis and therapeutic decisions
Hadas Neuman, Israel – IgTreeZ: A toolkit for immunoglobulin gene lineage tree analysis
Stephanie C. Talker, Switzerland – Single-cell RNA sequencing reveals striking heterogeneity of mononuclear phagocytes in bovine mesenteric lymph nodes
Wojciech Lason, United Kingdom – Pan-cancer survey of tumour mass dormancy and underlying mutational processes
Matti Hoch, Germany – Investigating the role of multicomponent multitarget drug Tr14 in inflammation resolution using in silico perturbation experiments
Workshop – WS.T4.02
Cancer Immunotherapy – Adaptive Immune Responses
Date & Time: September 3, 2021 / 17:15 – 18:30
Chairs:  TBA
Emre Balta, Germany – Antioxidant empowerment enhances antitumor functions of HER2-specific CAR T cells
Maik Luu, Germany – Microbial short-chain fatty acids enhance CD8+ T cell-mediated cancer immunotherapy
Maarten K. Nijen Twilhaar, Netherlands – Toll-like receptor ligand inclusion in GM3-containing liposomes induces potent dendritic cell maturation and T cell responses
Emiliya Stoyanova, Bulgaria – Anti-tumor Properties of Epitope-Specific Vaccine in Murine Model of Melanoma
Rebeca F Megino, Spain – Patient-specific cellular models for Sézary syndrome immunotherapy
Agata Mlynska, Lithuania – Modeling of dendritic cell vaccines for ovarian cancer immunotherapy using cell lines of different molecular profiles
Katharina Grabmeier Pfistershammer, Austria – Low frequency of differentiated CD3+CD27-CD28- T cells at enrollment predicts a favorable response to CAR T cell therapy in patients with DLBCL
Workshop – WS.T4.03
Cancer Immunotherapy – Innate Immune Responses
Date & Time: September 4, 2021 / 12:00 – 13:15
Chairs:  TBA
Maria A Streltsova, Russia – Transduction of NK cells with TYPOBP gene increases their functional activity and the NKp44 receptor expression level
Eduardo Moreo, Spain – Intravesical bacterial immunotherapy for bladder cancer can elicit tumor-specific immunity and relies on the capacity of the bacteria to infect and persist in the bladder
Maite Alvarez, Spain– Intratumoral Co-injection of the Poly I:C-derivative BO-112 and a STING Agonist Synergize to Achieve Local and Distant Anti-tumor Efficacy
Yunjie Wu, Norway – NK cells release subsets of extracellular vesicles with distinct profiles and tumor-targeting abilities
Sen Ma, Netherlands – In vitro results of first in class targeted therapy in Uveal Melanoma suggest immunostimulatory capacity
Sandra Lara, Sweden – Intravesical bacterial immunotherapy for bladder cancer can elicit tumor-specific immunity and relies on the capacity of the bacteria to infect and persist in the bladder
Ekaterina Pylaeva, Germany – Targeting glycosaminoglycan-CCL2 interactions prevents the immunosuppressive polarization of myeloid cells and provides an anti-tumor immune response
Workshop – WS.T4.04
Therapy in Autoimmunity and Allergies
Date & Time: September 2, 2021 / 17:15 – 18:30
Chairs: TBA
Mercedes Lopez Santalla, Spain – Protective long-term effects of mesenchymal stromal/stem cell-based therapy in experimental colitis is mediated by induction of an innate immune memory-like response
Isabelle Ote, Belgium – MOG-derived Imotope™, inducing cytolytic CD4+ T cells and reducing EAE manifestations in mice, as novel antigen-specific immunotherapy for multiple sclerosis
Andres Paris, Spain – Functionalization of tolerogenic dendritic cells with iron oxide magnetic nanoparticles for their magnetic retention
Evelien Schurgers, Belgium – Immunotherapy with apitopes® blocks the immune response to S-antigen in HLA-DR transgenic mice
Hannah K Fitzgerald, Ireland -Aromatic ketoacids represent novel therapies for inflammatory diseases through activation of the Nrf2/HO-1 pathway and suppression of pro-inflammatory responses in primary human immune cells
Josefine Ruder, Switzerland – Immune Reconstitution after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Nikola Ralchev Ralchev, Bulgaria – Selective elimination of allergen-specific B lymphocytes in chronic mouse house dust mite allergy model
Workshop – WS.T4.05
Vaccines in Immunotherapy
Date & Time: September 1, 2021 / 11:15 – 12:30
Chairs: TBA
Marina Bekić, Serbia – Phosphonated cellulose nanocrystals potentiate Th1 polarizing capacity of monocyte-derived dendritic cells
Noémi Anna Nagy, Netherlands – Liposomal vitamin D3 and retinoic acid induce tolerogenic dendritic cells
Marko Šustić, Croatia – Cytomegalovirus vector expressing NKG2D ligand generates superior CD8 T cell response with distinct phenotypical and functional features
Ioanna Zerva, Greece – Immunotherapy-on-chip against an experimental sepsis model
Lachlan Paul Deimel, United Kingdom – Mucosal administration of polyethylenimine in formulation with SARS-SoV-2 spike elicits potent neutralising responses
Jorieke Weiden, Switzerland – Probing the importance of valency and spatial organization of immune regulator PD-1 with DNA-based nanomaterials
Beka Solomon, Israel – Inhibition of endocytic BACE1 activity based on blocking the beta –secretase cleavage site on the APP via antibodies
Workshop – WS.T4.06
Innovative Technologies and Immunotherapies
Date & Time: September 2, 2021 / 11:30 – 12:45
Chairs: TBA
Antonia Efstathiou, Greece – Proteomic analysis of exosomes highlights their role in specific-signaling pathways’ modulation during Leishmania infection in macrophage
Charline Sommer, Germany – Drafting an evidence-based immune-related adverse outcome pathway of interleukin-2-induced adverse effects on human lung tissue
Thomas S Fulford, Australia – A lateral flow assay to detect neutralising antibodies against SARS-CoV-2
Jorge Gallego-Valle, Spain – Avidin-based Universal CAR regulatory T cells (UniCAR-Tregs): a versatile approach for future immunotherapy
Alexander Leithner, United Kingdom – A supported lipid bilayer platform to study the impact of bi-specific engager architecture on T cell activation
Laura Wilkins, United Kingdom – Pembrolizumab drug levels and anti-drug antibodies: measurement in two real-world centres
Nuno GB Neto, Ireland – Single-cell metabolic profiling of macrophage polarization by fluorescence lifetime imaging microscopy (FLIM)